Exploratory celiotomy for cervical carcinoma: the role of histologic grading

Upper abdominal cytoreduction and thoracoscopy for advanced epithelial ovarian cancer: unanswered questions and the impact on treatment.

BJOG : an international journal of obstetrics and gynaecology·2011

Feasibility of intravenous gemcitabine and an intraperitoneal platinum agent in the treatment of ovarian cancer.

Journal of chemotherapy (Florence, Italy)·2011

Correlation of extreme drug resistant assay results and progression-free survival following intraperitoneal chemotherapy for advanced ovarian cancer.

Journal of chemotherapy (Florence, Italy)·2010

Metastatic leiomyosarcoma diagnosed after uterine artery embolization.

European journal of gynaecological oncology·2009

Monitoring styles in women at risk for cervical cancer: implications for the framing of health-relevant messages.

Annals of behavioral medicine : a publication of the Society of Behavioral Medicine·2008

Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2007

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Gynecologic oncology·2026

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Gynecologic oncology·2026

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Gynecologic oncology·2026

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).

Gynecologic oncology·2026

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Gynecologic oncology·2026

Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.

Gynecologic oncology·2026

Small intestine melanosis caused by clofazimine: A case report.

Medicine·2026

A retrospective comparative study of CT and MRI findings of different types of pancreatic serous cystic neoplasms: Correlation with histopathology.

Medicine·2026

Related Experiment Videos

Exploratory celiotomy for cervical carcinoma: the role of histologic grading

Related Concept Videos

Upper abdominal cytoreduction and thoracoscopy for advanced epithelial ovarian cancer: unanswered questions and the impact on treatment.

Feasibility of intravenous gemcitabine and an intraperitoneal platinum agent in the treatment of ovarian cancer.

Correlation of extreme drug resistant assay results and progression-free survival following intraperitoneal chemotherapy for advanced ovarian cancer.

Metastatic leiomyosarcoma diagnosed after uterine artery embolization.

Monitoring styles in women at risk for cervical cancer: implications for the framing of health-relevant messages.

Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma.

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.

Small intestine melanosis caused by clofazimine: A case report.

A retrospective comparative study of CT and MRI findings of different types of pancreatic serous cystic neoplasms: Correlation with histopathology.

Related Experiment Videos

Exploratory celiotomy for cervical carcinoma: the role of histologic grading

Related Concept Videos

Related Articles